Hypofractionated short course radiation therapy for recurrent ovarian cancer
For well-selected patients, particularly those with oligometastatic disease, HFRT should be considered as an additional treatment option for recurrent ovarian cancer.
Authors
- Higinia R. Cárdenes (ORCID: https://orcid.org/0000-0001-6559-1807)
- Evelyn Cantillo (ORCID: https://orcid.org/0000-0001-6269-8748)
- Melissa Kristen Frey (ORCID: https://orcid.org/0000-0002-6705-1211)
- Jeff Lin (ORCID: https://orcid.org/0009-0005-3630-0288)
- Kevin Holcomb (ORCID: https://orcid.org/0000-0002-6916-5271)
- Eloise Chapman-Davis
- Emily Miller (ORCID: https://orcid.org/0000-0003-4367-1878)
- Amita Kulkarni
Institutions
- Cornell University (US)
- Presbyterian Hospital (US)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1016/j.gore.2026.102021
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00